Opi­oids, price-fix­ing and now kick­backs. Pros­e­cu­tors add an­oth­er ‘en­rich­ing’ scheme to the claims against Te­va

Te­va Phar­ma­ceu­ti­cals $TE­VA is in le­gal trou­ble again, this time for al­leged­ly de­fraud­ing Medicare.

On Tues­day, fed­er­al pros­e­cu­tors sued the Is­raeli drug­mak­er, ac­cus­ing them of pay­ing hun­dreds of mil­lions of dol­lars to two foun­da­tions as part of a scheme to boost sales for the block­buster mul­ti­ple scle­ro­sis drug Co­pax­one. The suit comes af­ter a se­ries of le­gal chal­lenges — large­ly over their role in the opi­oid cri­sis and in price-fix­ing schemes with oth­er gener­ic pro­duc­ers — that have helped knock Te­va from its for­mer po­si­tion as one of the world’s top drug­mak­ers.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER